Rare diseases
Investigational molecules
Locations
Ulitsa Starozagorska 16, 6102 Kazanlak, Bulgaria
Multiprofile Hospital For Active Treatment Dr. Hristo Stambolski EOOD in Kazanlak, Bulgaria specialises in clinical trials of conditions such as Schizophrenia, Major depression, Bipolar I disorder, Bipolar disorder, and other specialisations. This site conducts important research.
The Department of Psychiatry at Multiprofile Hospital for Active Treatment Dr. Hristo Stambolski EOOD is dedicated to improving care for patients with schizophrenia, bipolar disorder, and major depressive disorder. Current research evaluates new therapies that target core symptoms, enhance daily functioning, and monitor long‑term safety.
Ten active trials, overseen by five investigators, are underway at the Kazanlak site, contributing valuable data to the European mental‑health research landscape.
Clinical trials currently enrolling participants at this site.
Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia
BulgariaA study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia
BulgariaA study to evaluate the effectiveness and safety of NBI-1117570 in adults with schizophrenia who require hospital treatment.
BulgariaA study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder
BulgariaEvaluation of Trazodone Hydrochloride for Improving Emotional Blunting in Patients with Major Depressive Disorder
BulgariaA study to evaluate the safety and effectiveness of azetukalner in patients with bipolar depression
BulgariaA study to evaluate the effectiveness and safety of azetukalner in patients experiencing depressive episodes associated with bipolar disorder.
BulgariaLong-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms
BulgariaStudy on the Effects of BH-200 (Nelivaptan) for Patients with Major Depressive Disorder
BulgariaStudy on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients
BulgariaStudy of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms
BulgariaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
